Amarin, Vivus, and Teva: The 3 Biggest Management Shake-Ups of 2013
Forget Steve Ballmer and Ron Johnson. These are the management shake-ups that health-care investors were watching this year.
3 Surprising Ways Smartphones Can Help Fight Obesity
How are Nike, Weight Watchers, and VIVUS using Apple and Google smartphones to combat rising obesity rates in America?
The Weight Loss Drug Company Investors Need to Watch Out For
Big names like GlaxoSmithKline, Arena, VIVUS, and Orexigen are probably well-known among obesity market watchers, but this less publicized company out of Massachusetts is poised to change the landscape in coming years.